Cheap, generic anti-depressant may reduce severe Covid-19 disease, study finds

View Content

CNN’s discussion on the latest study that found that fluvoxamine could reduce the risk of having severe COVID-19 symptoms. “Fluvoxamine may reduce the production of inflammatory molecules called cytokines that can be triggered by SARS-COV-2 infection.”

Print Friendly, PDF & Email

Leave a Reply

Your email address will not be published. Required fields are marked *